Usted buscó: dysplasi (Danés - Inglés)

dysplasi
dysplasia

ektodermal dysplasi
anhidrotic hereditary ectodermal dysplasia

bronchopulmunær dysplasi.
within the last 6 months.

kongenit ektodermal dysplasi
congenital ectodermal dysplasia

cervikal dysplasi, amenorre
cervical dysplasia, amenorrhoea

septo-optisk dysplasi
septo-optic dysplasia

Åndedrætsbesvær (bronkopulmonal dysplasi),
breathing problems (bronchopulmonary dysplasia),

kranial malformation med hydrocefali og facial dysplasi
cloverleaf skull

højt differentieret dysplasi i barretts øsofagus på 7 cm
high-grade dysplasia in barrett 's oesophagus of 7 cm

højt differentieret dysplasi i barretts øsofagus på < 7 cm
high-grade dysplasia in barrett's oesophagus of < 7 cm

keratosis palmoplantaris med ektodermal anhidrotisk dysplasi(franceschetti)
palmoplantar keratosis with ectodermal anhidrotic dysplasia after franceschetti

kort baggrundsbeskrivelse og introduktion af barrets øsofagus og højt differentieret dysplasi.
brief background and introduction to barrett’s oesophagus and high grade dysplasia

tabel 1 bivirkninger i profylaktiske kliniske forsøg med præmature børn og børn med bronkopulmonal dysplasi
table 1 undesirable effects in prophylactic clinical studies with premature and bronchopulmonary dysplasia paediatric populations

enogfyrre procent af patienterne fremviste normalt pladeepitel, og 49% havde fravær af dysplasi.
forty-one percent of patients showed normal squamous cell epithelium and 49% had absence of dysplasia.

bronkopulmonal dysplasi (abnormt lungevæv, der sædvanligvis findes hos for tidligt fødte børn) ,
dysplasia (abnormal lung tissue, usually found babies who were born prematurely) within the last 6 months,

det er ukendt, om golimumab-behandling har indvirkning på risikoen for udvikling af dysplasi eller coloncancer.
it is not known if golimumab treatment influences the risk for developing dysplasia or colon cancer.

· fjernelse af højt differentieret dysplasi (hgd) hos patienter med barretts øsofagus (bo)
· ablation of high-grade dysplasia (hgd) in patients with barrett 's oesophagus (bo)

· hpv 6, 11, 16 og 18 ansvarlige for 35 ­ 50% af cin 1 eller low-grade cervikal dysplasi.
hpv 6, 11, 16 and 18 are responsible for 35 to 50% of cin 1 or low grade cervical dysplasia.

med de nuværende resultater er det uvist, om infliximabbehandling påvirker risikoen for at udvikle dysplasi eller colon cancer (se pkt.4. 8) .
with current data it is not known if infliximab treatment influences the risk for developing dysplasia or colon cancer (see section 4.8) .

forandringer i uterus (endometrieatrofi) og knoglevækstplade (fortykkelse af epifyse eller dysplasi af brusken) menes at være relateret til den farmakologiske virkning af sunitinib.
changes in the uterus (endometrial atrophy) and bone growth plate (physeal thickening or dysplasia of cartilage) are thought to be related to the pharmacological action of sunitinib.